Peter Ping Lin
Impact in
- Cancer Research top 5%
- Cancer Genomics and Diagnostics
- Oncology top 5%
- Cancer Cells and Metastasis
Papers in
- Oncology 33
- Cancer Cells and Metastasis 26
- Lung Cancer Research Studies 5
-
- Cancer Genomics and Diagnostics 17
- Co-authors
- Marilyn G. Farquhar (8 shared papers)John Hakimi (3 shared papers)Daisy Dandan Wang (18 shared papers)Kurt Hollfelder (1 shared paper)ALVIN S. STERN (1 shared paper)Y.-C. E. Pan (1 shared paper)Chang Su (1 shared paper)Ueli Gubler (1 shared paper)
- Journals
- Cancer Letters (5 papers)Oncotarget (5 papers)BMC Cancer (4 papers)Frontiers in Oncology (3 papers)Journal of Biological Chemistry (3 papers)
- Partner nations
- United StatesChinaGermany
In The Last Decade
Peter Ping Lin
67 papers receiving 2.8k citations
Peers
Comparison fields: 5 of 102
- Cancer Research 587
- Oncology 999
- Immunology 611
- Immunology and Allergy 115
- Cell Biology 255
Countries citing papers authored by Peter Ping Lin
This map shows the geographic impact of Peter Ping Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Ping Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Ping Lin more than expected).
Fields of papers citing papers by Peter Ping Lin
This network shows the impact of papers produced by Peter Ping Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Ping Lin. The network helps show where Peter Ping Lin may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Ping Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 72 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1995 | 363 | |
| 2 | 1991 | 190 | |
| 3 | 2019 | 160 | |
| 4 | 1998 | 137 | |
| 5 | 1999 | 118 | |
| 6 | 2005 | 99 | |
| 7 | 2009 | 86 | |
| 8 | 2017 | 86 | |
| 9 | 2009 | 80 | |
| 10 | 2014 | 74 | |
| 11 | 2017 | 73 | |
| 12 | 1993 | 72 | |
| 13 | Inhibition of tumor necrosis factor-alpha (TNF-alpha) production and arthritis in the rat by GW3333, a dual inhibitor of TNF-alpha-converting enzyme and matrix metalloproteinases. | 2001 | 66 |
| 14 | 2019 | 65 | |
| 15 | 2016 | 64 | |
| 16 | 2015 | 57 | |
| 17 | 2015 | 57 | |
| 18 | 2015 | 55 | |
| 19 | 2020 | 55 | |
| 20 | 2000 | 52 |
About Peter Ping Lin
Peter Ping Lin is a scholar working on Oncology, Cancer Research, Cell Biology, Immunology and Molecular Biology, having authored 72 papers that have together received 2.9k indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (26 papers), Cancer Genomics and Diagnostics (17 papers), Cellular transport and secretion (7 papers), Lung Cancer Research Studies (5 papers), Monoclonal and Polyclonal Antibodies Research (5 papers), Angiogenesis and VEGF in Cancer (4 papers), Cancer Research and Treatments (3 papers) and Ion channel regulation and function (3 papers). The work is most often cited by research in Cancer Research (587 citations), Oncology (999 citations), Immunology (611 citations), Immunology and Allergy (115 citations) and Cell Biology (255 citations). Peter Ping Lin has collaborated with scholars based in United States, China and Germany. Frequent co-authors include Marilyn G. Farquhar, John Hakimi, Daisy Dandan Wang, Kurt Hollfelder, ALVIN S. STERN, Y.-C. E. Pan, Chang Su, Ueli Gubler, Maurice K. Gately and Robert Hofmeister. Their work appears in journals such as Cancer Letters, Oncotarget, BMC Cancer, Frontiers in Oncology and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.